The Joint Corp. expands board with new director appointment

SCOTTSDALE, Ariz. - The Joint Corp. (NASDAQ: JYNT), a prominent operator and franchisor of chiropractic clinics with a market capitalization of approximately $158 million, announced today the appointment of Sandi Karrmann as a new member of its Board of Directors. The addition of Karrmann increases the board’s size to eight directors. According to InvestingPro analysis, the company maintains a strong balance sheet with more cash than debt, positioning it well for future growth initiatives.

Karrmann brings over two decades of human resources experience to the board, having held senior roles at various healthcare and consumer companies, including Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International. Her expertise is expected to bolster The Joint Corp.’s strategic initiatives focused on talent development, employee engagement, and franchisee support.

CEO Sanjiv Razdan expressed confidence in Karrmann’s ability to contribute to the company’s goals, emphasizing the importance of building a strong organizational culture and improving the overall patient experience to drive sales and profitability.

Karrmann shared her enthusiasm for joining The Joint Corp., praising the company’s innovative approach to making chiropractic care accessible and affordable. She is looking forward to supporting the company’s evolution into a world-class franchisor.

The Joint Corp. is known for its unique retail healthcare business model, which was introduced in 2010. With over 950 locations across the United States and more than 14 million annual patient visits, The Joint Chiropractic has established itself as a leader in the chiropractic industry. The company has received recognition from various franchise and entrepreneurship publications for its growth and franchise opportunities.

This announcement is based on a press release statement and follows recent company developments, including the release of their annual report and the ongoing implementation of their 2025 strategic priorities. The Joint Corp. aims to continue its growth trajectory and maintain its status as a key player in the chiropractic sector.

In other recent news, The Joint Corp. reported its Q1 2025 earnings, showcasing a notable earnings per share (EPS) of $0.05, which exceeded the forecasted $0.01. However, the company faced challenges with its revenue, reporting $13.1 million against an expected $27.5 million. This mixed financial performance highlights both strengths in operational execution and challenges in meeting revenue targets. Additionally, The Joint Corp. has appointed Christopher M. Grandpre to its board of directors as part of its strategy for sustained growth, focusing on new clinic openings and system-wide sales.

The company’s ongoing transition to a pure play franchisor is progressing, with 87% of its 969 clinics now franchise-operated. Analysts from B. Riley Securities have shown interest in the refranchising process, noting the potential for increased profitability once the transition is complete. The Joint Corp. is also enhancing its business model by launching a new mobile app and implementing revenue management strategies. These developments are part of the company’s broader efforts to strengthen its core operations and improve profitability.

Furthermore, The Joint Corp. continues to focus on franchise growth, having opened five new franchise clinics in the quarter. The company also projects system-wide sales between $550 million and $570 million for 2025, with plans to open 30 to 40 new franchise clinics. These strategic moves are indicative of The Joint Corp.’s commitment to expanding its footprint and optimizing its operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.